S&P 500   3,839.96
DOW   31,124.86
QQQ   322.54
S&P 500   3,839.96
DOW   31,124.86
QQQ   322.54
S&P 500   3,839.96
DOW   31,124.86
QQQ   322.54
S&P 500   3,839.96
DOW   31,124.86
QQQ   322.54
Log in
NASDAQ:TRNS

Transcat Stock Forecast, Price & News

$36.69
-0.01 (-0.03 %)
(As of 01/20/2021 10:31 AM ET)
Add
Compare
Today's Range
$36.06
Now: $36.69
$36.69
50-Day Range
$31.39
MA: $33.93
$35.92
52-Week Range
$16.50
Now: $36.69
$36.70
Volume13 shs
Average Volume30,280 shs
Market Capitalization$272.79 million
P/E Ratio40.32
Dividend YieldN/A
Beta0.7
Transcat, Inc. provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, oil and gas and alternative energy, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.
Transcat logo

MarketRank

Overall MarketRank

1.67 out of 5 stars

Computer And Technology Sector

195th out of 1,517 stocks

Instruments To Measure Electricity Industry

3rd out of 15 stocks

Analyst Opinion: 1.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Instruments to measure electricity
Sub-IndustryN/A
Current SymbolNASDAQ:TRNS
CUSIPN/A
Phone585-352-7777
Employees722

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$173.10 million
Cash Flow$2.19 per share
Book Value$9.09 per share

Profitability

Net Income$8.07 million

Miscellaneous

Market Cap$272.79 million
Next Earnings Date2/2/2021 (Estimated)
OptionableNot Optionable
$36.69
-0.01 (-0.03 %)
(As of 01/20/2021 10:31 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Transcat (NASDAQ:TRNS) Frequently Asked Questions

How has Transcat's stock price been impacted by Coronavirus (COVID-19)?

Transcat's stock was trading at $27.83 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TRNS stock has increased by 31.8% and is now trading at $36.69.
View which stocks have been most impacted by COVID-19
.

Is Transcat a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Transcat stock.
View analyst ratings for Transcat
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Transcat?

Wall Street analysts have given Transcat a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Transcat wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Transcat's next earnings date?

Transcat is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Transcat
.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) released its earnings results on Tuesday, October, 27th. The scientific and technical instruments company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.10. The scientific and technical instruments company earned $41.61 million during the quarter, compared to analysts' expectations of $40.25 million. Transcat had a net margin of 4.01% and a return on equity of 10.08%.
View Transcat's earnings history
.

What price target have analysts set for TRNS?

3 analysts have issued 1 year price objectives for Transcat's stock. Their forecasts range from $36.00 to $42.00. On average, they anticipate Transcat's stock price to reach $39.67 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price.
View analysts' price targets for Transcat
or view Wall Street analyst' top-rated stocks.

Who are some of Transcat's key competitors?

What other stocks do shareholders of Transcat own?

Who are Transcat's key executives?

Transcat's management team includes the following people:
  • Mr. Lee D. Rudow, Pres, CEO & Director (Age 56, Pay $586.39k)
  • Mr. Michael W. West, VP of Distribution & Marketing (Age 49, Pay $289.11k)
  • Mr. Mark A. Doheny, Chief Financial Officer
  • Ms. Leanne E. Branham, VP of Service Operations (Age 56)
  • Mr. Scott D. Deverell, Corp. Controller & Principal Accounting Officer (Age 54)
  • Mr. James M. Jenkins J.D., Gen. Counsel & VP of Corp. Devel. (Age 56)
  • Ms. Jennifer J. Nelson, VP of HR (Age 49)

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

Who are Transcat's major shareholders?

Transcat's stock is owned by a number of institutional and retail investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.26%). Company insiders that own Transcat stock include Carl E Sassano, Charles P Hadeed, Gary J Haseley, John T Smith, Lee D Rudow, Michael Tschiderer, Richard J Harrison, Robert A Flack and Scott Deverell.
View institutional ownership trends for Transcat
.

Which institutional investors are selling Transcat stock?

TRNS stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. Company insiders that have sold Transcat company stock in the last year include Carl E Sassano, Charles P Hadeed, Lee D Rudow, and Scott Deverell.
View insider buying and selling activity for Transcat
or view top insider-selling stocks.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $36.69.

How big of a company is Transcat?

Transcat has a market capitalization of $272.79 million and generates $173.10 million in revenue each year. The scientific and technical instruments company earns $8.07 million in net income (profit) each year or $1.08 on an earnings per share basis. Transcat employs 722 workers across the globe.

What is Transcat's official website?

The official website for Transcat is www.transcat.com.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at 585-352-7777 or via email at [email protected]

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.